Memeron Alzheimer's Drug Offers Hope to Patients and Caregivers

“ A new Alzheimer's drug has been developed and now available OTC. Initial patient results have been promising with increased memory functions, greater verbal fluency, and elevated mood all being reported. For more information visit www.memeron.com. ”

Galantamine Molecule

Share on            

Email Friend     Contact Author

(iHealthWire.Org) – Memeron is a new Alzheimer's drug treatment utilizing the latest research in neurobiology and neuropharmacology being touted as an unparalleled treatment option for patients and caregivers. Memeron is a new compound of Galantamine Hydrobromide and Alpha GPC (choline alfoscerate), which helps to reduce beta-amyloid plaques common in AD patients, promote neurogenesis and brain cell renewal, and produce additional acetylcholine for mental functions involved with memory.

Memeron is being compared to Alzheimer's drugs currently on the market including Aricept (donepezil), Exelon (Rivastigmine), and Razadyne. However, Memeron is possibly a superior treatment for Alzheimer's due to its ability to not only prevent the breakdown of acetylcholine, but to actually synthesize additional acetylcholine through a complex process of biosynthesis.

One of the active ingredients of Memeron is a drug called Galantamine that has been studied extensively in Alzheimer's patients for over 50 years and was recently approved by the FDA to treat mild to moderate Alzheimer's disease. Galantamine was originally developed by a Bulgarian pharmacologist who accidentally discovered the neurological benefits of the drug when he noticed local villagers were rubbing their foreheads with a plant known as a caucasian snowdrop (Galanthus nivalis).

More recently, neuroscientists and researchers have explored the properties of Galantamine and have found its ability to increase neurotransmitter levels essential to memory functions. Researchers have also found that Galantamine is synergistic with acetylcholine precursors such as Alpha GPC. Memeron harnesses the unique synergy of Galantamine and Alpha GPC into a single treatment.

More information can be found on the memeron website at http://www.memeron.com